期刊文献+

白念珠菌对特比萘芬、咪康唑和制霉菌素的敏感性测定 被引量:1

Antifungal Susceptibility Testing of Clinical Isolates of Candida Albicans to Terbinafine,Miconazole and Nystatin
下载PDF
导出
摘要 目的测定白念珠菌的菌丝相和酵母相对特比萘芬、咪康唑和制霉菌素的敏感性。方法参照美国临床实验室标准化研究所制定的M27-A3方案,测定特比萘芬、咪康唑和制霉菌素对从临床获得的14株白念珠菌的菌丝相和酵母相MIC值。结果 (1)特比萘芬对白念珠菌的菌丝相及酵母相MIC结果差异无统计学意义,且其对白念珠菌敏感株和耐药株间MIC结果差异亦无统计学意义;(2)咪康唑对白念珠菌的菌丝相及酵母相MIC结果差异有统计学意义,后者明显较低;该药对白念珠菌敏感株和耐药株间MIC结果的差异亦有统计学意义,后者明显较高;(3)制霉菌素对白念珠菌敏感株和耐药株间MIC结果差异无统计学意义,但制霉菌素对白念珠菌菌丝相及酵母相MIC结果差异有统计学意义,后者明显较高。结论特比萘芬对白念珠菌菌丝相无抑制效果,且与氟康唑间无交叉耐药。咪康唑与氟康唑对白念珠菌存在交叉耐药,且咪康唑对白念珠菌酵母相抑制效果优于菌丝相。制霉菌素对白念珠菌菌丝相有抑制效果,且与氟康唑间无交叉耐药。 ObjectiveTo determine the in vitro susceptibility of Candida albicans to terbinafine,miconazole and nystatin in hyphal form and yeast form.Methods The MICs of 14 strains of Candida albicans to terbinafine,miconazole and nystatin in hyphal form and yeast form were determined according to Clinical and Laboratory Standards Institute(CLSI)M27-A3 methods.Results ①The MICs of terbinafine against Candida albicans showed no difference under hyphal form and yeast form,and the MICs of terbinafine against Candida albicans between sensitive and resistant strains were also no significant difference; ②The MICs of miconazole against Candida albicans in yeast form were significantly lower than hyphal form,and the MICs of terbinafine against sensitive strains were also significantly lower than resistant strains; ③The MICs of terbinafine against Candida albicans showed no difference between sensitive and resistant strains,however,the MICs of miconazole against Candida albicans in yeast form were significantly higher than hyphal form.Conclusion Terbinafine had no inhibitory effect against Candida albicans in hyphal form,and no cross resistance with fluconazole.There was cross resistance between miconazole and fluconazole against Candida albicans,and the inhibitory effect of miconazole on yeast form was better than hyphal form.Nystatin had an inhibitory effect against Candida albicans in hyphal form and no cross resistance with fluconazole.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2018年第2期163-165,共3页 The Chinese Journal of Dermatovenereology
基金 国家自然科学基金(81471925)
关键词 特比萘芬 咪康唑 制霉菌素 白念珠菌 菌丝相 酵母相 Terbinafine Miconazole Nystatin Candida albicans Hyphal form Yeast form
  • 相关文献

参考文献5

二级参考文献32

  • 1中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案)[J].中华妇产科杂志,2004,39(6):430-431. 被引量:490
  • 2刘小平,樊尚荣,李建武.妊娠期妇女外阴阴道念珠菌病的病原学和治疗研究[J].中华围产医学杂志,2004,7(4):220-222. 被引量:21
  • 3刘朝晖,廖秦平.外阴阴道假丝酵母菌病的致病菌研究[J].中国实用妇科与产科杂志,2005,21(3):149-151. 被引量:63
  • 4燕华玲,王爱平,万喆,李若瑜.特比萘芬对白念珠菌菌丝相和酵母相敏感性的比较[J].中华皮肤科杂志,2005,38(8):515-515. 被引量:9
  • 5Sobel JD,Faro S,Force RW,et al.Vulvovaginal candidiasis:epidemiologic,diagnostic,and therapy considerations[J].Am J Obstet Gynecol,1998,178(2):203-211.
  • 6CDC.Sexually transmitted diseases treatment guideline 2002[J].MMWR,2002,51(6):45-48.
  • 7Bulik CC,Sobel JD,Nailor MD.Susceptibility profile of vaginal isolates of candida albicans prior to and following fluconazole introduction-impact of two decades[J].Mycoses,2009,52(26):Epub ahead of print.
  • 8Richter SS,Galask RP,Messer SA,et al.Antifungal susceptibilities of candida species causing vulvovaginitis and epidemiology of recurrent cases[J].J Clin Microbiol,2005,43(5):2155-2162.
  • 9Mc Caig LF,Mc Neil MM.Trends in prescribing for vulvovaginal candidiasis in the united states[J].Pharmacoepidemiol Drug Saf,2004,14(2):113-120.
  • 10Hudson MMT.Antifungal resistance and over-the-counter availability in the UK:a current perspective[J].J Antimicrob Chemother,2001,48(3):345-350.

共引文献38

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部